TransMedics Other Stockholder Equity from 2010 to 2024

TMDX Stock  USD 87.11  6.50  8.06%   
TransMedics Other Stockholder Equity yearly trend continues to be fairly stable with very little volatility. Other Stockholder Equity is likely to outpace its year average in 2024. During the period from 2010 to 2024, TransMedics Other Stockholder Equity regression line of annual values had significance of  0.94 and arithmetic mean of  6,840,808. View All Fundamentals
 
Other Stockholder Equity  
First Reported
2018-06-30
Previous Quarter
-218 K
Current Value
-265.4 M
Quarterly Volatility
102.6 M
 
Covid
Check TransMedics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TransMedics' main balance sheet or income statement drivers, such as Interest Expense of 11.3 M, Selling General Administrative of 125.5 M or Research Development of 22.2 M, as well as many indicators such as Price To Sales Ratio of 10.09, Dividend Yield of 0.0 or PTB Ratio of 19.64. TransMedics financial statements analysis is a perfect complement when working with TransMedics Valuation or Volatility modules.
  
Check out the analysis of TransMedics Correlation against competitors.

Latest TransMedics' Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of TransMedics Group over the last few years. It is TransMedics' Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TransMedics' overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Very volatile
   Other Stockholder Equity   
       Timeline  

TransMedics Other Stockholder Equity Regression Statistics

Arithmetic Mean6,840,808
Coefficient Of Variation737.55
Mean Deviation26,395,251
Median(417,000)
Standard Deviation50,454,447
Sample Variance2545.7T
Range248.9M
R-Value0.02
Mean Square Error2740.2T
R-Squared0.0005
Significance0.94
Slope247,048
Total Sum of Squares35639.1T

TransMedics Other Stockholder Equity History

2024-192.4 K
2023-202.5 K
2022-225 K
202168 M
2020-95 K
2019-105.3 M
2018-101 K

About TransMedics Financial Statements

TransMedics investors use historical fundamental indicators, such as TransMedics' Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in TransMedics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Stockholder Equity-202.5 K-192.4 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.